UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022409
Receipt number R000025828
Scientific Title Prospective study of embolization of thoracic wall artery for tumors of thoracic wall and pleura
Date of disclosure of the study information 2016/05/23
Last modified on 2019/10/02 11:29:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study of embolization of thoracic wall artery for tumors of thoracic wall and pleura

Acronym

Prospective study of embolization of thoracic wall artery for thoracic wall tumors

Scientific Title

Prospective study of embolization of thoracic wall artery for tumors of thoracic wall and pleura

Scientific Title:Acronym

Prospective study of embolization of thoracic wall artery for thoracic wall tumors

Region

Japan


Condition

Condition

Malignant tumors of thoracic wall and pleura

Classification by specialty

Pneumology Hematology and clinical oncology Chest surgery
Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

For malignant tumors of thoarcic wall or pleura, which can be hardly treated by surgery, radiation, and chemotherapy, feasibility and effectivenes of embolization of tumor feeding artery using NBCA are examined.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

1. Adverse event within one week of treatment
2. Antitumor effect within 3 months

Key secondary outcomes

1. Tumor shrinking period within 1 year
2. Local recurrence rate within 1 year
3. Prognosis in 3 years


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

NBCA is used during the embolization in less than 10ml.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

110 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Malignant tumors of thoraci wall and pleura which can be hardly treated by surgery, radiation therapy, and chemotherapy.
2. Resectable tumors, which had better to be shrinked before surgery.

Key exclusion criteria

1

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Nomori, MD

Organization

Kameda Medical Center

Division name

Thoracic Surgery

Zip code


Address

929 Higashi-cho Kamogawa City, Chiba, 296-8602

TEL

0470-92-2211

Email

hnomori@qk9.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Nomori, MD

Organization

Kameda Medical Center

Division name

Thoracic Surgery

Zip code


Address

929 Higashi-cho Kamogawa City, Chiba, 296-8602

TEL

0470-92-2211

Homepage URL


Email

hnomori@qk9.so-net.ne.jp


Sponsor or person

Institute

Kameda Medical Center

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 17 Day

Date of IRB

2016 Year 05 Month 23 Day

Anticipated trial start date

2016 Year 05 Month 23 Day

Last follow-up date

2020 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 05 Month 23 Day

Last modified on

2019 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025828


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name